Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Drug Alcohol Depend. 2016 Oct 20;169:73–79. doi: 10.1016/j.drugalcdep.2016.10.017

Table 2.

Unadjusted and adjusted hazard ratios for factors related to initiation of prescription opioid injection among people who use drugs in Vancouver (n= 1580).

Variable Hazard Ratio (95% CI)*

Unadjusted p-value Adjusted p-value
Sex (Female vs. Male) 1.11 (0.86–1.44) 0.421
Age (Per year older) 1.00 (0.99–1.01) 0.654
Ethnicity (Caucasian vs. Non-Caucasian) 1.51 (1.16–1.96) 0.002 1.37 (1.04–1.79) 0.024
Education (≥ Sec. vs. < Sec.) 1.38 (1.07–1.77) 0.012 1.44 (1.12–1.87) 0.005
Follow-up Period (per 6-month interview interval) 0.95 (0.91–0.99) 0.008 0.97 (0.93–1.00) 0.063
Cohort
 ACCESS (vs. ARYS) 1.26 (0.88–1.79) 0.207
 VIDUS (vs. ARYS) 1.73 (1.25–2.40) <0.001
Downtown Eastside Residency** 1.85 (1.42–2.40) <0.001 1.31 (1.00–1.71) 0.047
Homelessness** 1.19 (0.91–1.56) 0.213
Incarcerated** 1.29 (0.91–1.84) 0.158
Addiction Treatment Enrolment**
 Non-methadone treatment (vs. none) 1.20 (0.80–1.81) 0.383 1.16 (0.76–1.75) 0.498
 Methadone treatment (vs. none) 4.46 (2.03–9.80) <0.001 2.96 (1.34–6.51) 0.007
 Methadone and non-methadone (vs. none) 2.45 (1.85–3.24) <0.001 1.37 (1.03–1.82) 0.031
Drug Dealing** 1.76 (1.34–2.31) <0.001 1.32 (1.00–1.76) 0.050
Sex work** 1.05 (0.68–1.64) 0.824
Heavy Alcohol Use** 0.78 (0.57–1.07) 0.121
Heroin Injection** 6.30 (4.83–8.20) <0.001 4.39 (3.24–5.95) <0.001
Heroin Non-injection** 1.54 (1.06–2.23) 0.023
Cocaine Injection** 2.23 (1.71–2.89) <0.001 1.40 (1.06–1.84) 0.018
Crack/coc. Non-injection** 1.69 (1.25–2.28) <0.001
Methamphetamine Injection** 2.16 (1.56–3.00) <0.001 1.71 (1.22–2.39) 0.002
Methamphetamine Non-injection** 0.91 (0.64–1.30) 0.619
Prescription Opioid Non-injection** 1.94 (1.22–3.09) 0.005 1.99 (1.25–3.17) 0.004
Marijuana Use** 1.04 (0.80–1.35) 0.773
Sexual Abuse** 1.12 (0.84–1.49) 0.441
Suicide Attempt** 1.56 (0.85–2.87) 0.150
*

95% Confidence Interval.

**

In the previous six months (yes vs. no), lagged to the previous follow-up to prescription opioid injection initiation assessment.